London, UK, Jan. 20, 2025 (GLOBE NEWSWIRE) — Freename, the leading multi-chain Web3 namespace platform, has integrated with Etherlink, a Layer 2 blockchain powered by Tezos Smart Rollups, to launch the new top-level domain “.etherlink“. The launch marks an important step in expanding blockchain domain adoption, enabling users to easily create Web3 identities and manage […]
(TSX:TCL-A),(TSX:TCL-B), MONTRÉAL, Jan. 20, 2025 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) (“TC Transcontinental” or the “Corporation“) and Capinabel inc. (“Capinabel”) announce the closing of a series of transactions resulting in the termination of the monetization of 3,950,000 TC Transcontinental Class B Shares (the “Class B Shares“) held by Capinabel (the “Transaction“). On August
Cemex announced today that the U.S. Department of Energy's (DOE) Office of Fossil Energy and Carbon Management (FECM) has selected a project for funding to develop a pioneering carbon capture, removal, and conversion test center at its cement plant in Knoxville, Tennessee. It will serve as a proving ground for innovative carbon capture technologies needed
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Signet Jewelers Limited ("Signet") (NYSE:SIG) concerning possible violations of federal securities laws. On January 14, 2025, Signet issued a press release announcing the company’s holiday sales results, comprising the 10-week period ending January
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=123797&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=123796&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Capri Holdings Limited (NYSE:CPRI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capri-holdings-lawsuit-submission-form?prid=123794&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123793&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Visa Inc. (NYSE:V) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/visa-inc-lawsuit-submission-form?prid=123790&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
NEW YORK, NY / ACCESSNEWSWIRE / January 20, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=123788&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call